Table 3.
Percentage Willing to Take the Drug Under Base Conditions | |||
---|---|---|---|
All | F | M | |
Results stratified by gender | |||
Number of subjects (N) | 100 | 28 | 72 |
Celecoxib | 15.0% | 14.3% | 15.3% |
Aspirin | 76.0% | 82.1% | 73.6% |
| |||
All | HGD | No HGD | |
| |||
Results stratified by history of HGD | |||
Number of subjects (N) | 100 | 45 | 55 |
Celecoxib | 15.0% | 20.0% | 10.9% |
Aspirin | 76.0% | 68.9% | 81.8% |
HGD = history of high-grade dysplasia.
P < 0.0001; difference in percentage willing to take the two drugs.